- INC Research Holdings, Inc. stock price today and history
INC Research Holdings, Inc. (INCR) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
INC Research Holdings, Inc. stock price, INCR
INC Research Holdings, Inc. stock chart:
INC Research Holdings, Inc. close price: 55.1
Stock price forecast:
DOWN TO -3.76%
Total forecasts: 90
Reached: 14 (15.56%)
Total Win: 34.21 (78.86%)
Showing 1-10 of 625 items.
|Date of Forecast||Stock Price||Target Price||Forecast Reached Date|
INC Research Holdings, Inc. latest news:
BRIEF-Amazon says to double research and development roles in London
* Amazon announces plans to double research and development
roles in london as it opens new uk head office
Dick's Sporting Goods downgraded on concerns about e-commerce shift
Dick's Sporting Goods Inc. was downgraded to peer perform at Wolfe Research on Tuesday based on concerns about the shift to e-commerce from bricks-and-mortar retail. "Given the challenging reads through the first half of 2017, we believe any share gain potential will largely be eroded away by current oversupply, with too many goods chasing too little demand," analysts led by Adrienne Yih wrote. There's also "limited evidence" that Dick's is snapping up market share from competitors that are leaving the sector, the note said. "We believe Dick's is susceptible to severe deleverage and leaves us skeptical of further store openings beyond the current outlined plans," the note said, with Yih adding that Dick's is "sacrificing gross margin for comp" in an effort to price competitively. Dick's shares are up 1.6% in Tuesday trading, but down nearly 33% for the year so far. The S&P 500 index is up 10.7% for 2017 to date.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
U.S. Reps urge DOE to jumpstart naval bomb-grade uranium program
Two Democratic lawmakers urged the U.S. Energy Department to move faster with a research program on converting nuclear reactors in the Navy's submarines and carriers from bomb-grade uranium to a safer fuel, a letter viewed by Reuters showed.
BRIEF-Perma-Fix Environmental Services seeks funding for co's unit PF Medical's R&D
Perma-Fix Environmental Services Inc(PESI) : * Says on July 20, provided notification to a potential investor of intent to seek funding for co's unit PF Medical's research and development. * Says due to potential funding deal not closing, PF Medical to proceed with seeking funding from alternative sources Source text: Further company coverage:
Lyft to Develop Self-Driving Car Technology in New Silicon Valley Facility
The ride-hailing company is opening a research center in Palo Alto, Calif., and plans to collaborate with automakers and tech companies.
UPDATE 1-U.S. taxable bond funds gather most cash since March -Lipper
(Adds details on mutual funds and ETFs, analyst quote, table,
By Trevor Hunnicutt
NEW YORK, July 20 (Reuters) - U.S. fund investors shifted
$7.6 billion to the safe harbor of taxable bonds during the most
recent week, Lipper data showed on Thursday, as Republicans
efforts to pass major healthcare policy stalled.
The bond funds took in the most cash since March, and the
rotation from domestic to international stocks accelerated, the
research service's data for the week ended
SAP quarterly profit shy of forecast on higher cloud costs
SAP, Europe's most valuable technology firm, posted rapid growth in internet-delivered cloud services, dampening near-term operating profit, which was slightly below forecasts the company blamed on higher cloud research and marketing costs.
Grocery shopping is no longer a one-stop experience
Half of Americans visit three or more stores to grocery-shop, research shows. That's bad news for traditional grocery-store chains.
Canada's Grand Challenges projects are using research and ingenuity to tackle global problems.
Want to get away with insider trading? Don't do this...
MIT research scientist who allegedly made $120K in illegal insider trading profits did Internet searches for the phrase: how sec detect unusual trade
MOVES-Credit Suisse taps Willoughby as senior advisor for healthcare group
Credit Suisse Group AG has appointed Robert Willoughby to the role of senior advisor for its healthcare investment banking group, according to a memo reviewed by Reuters and confirmed by a spokesman for Credit Suisse. Willoughby was previously a managing director and senior research analyst in the Credit Suisse equity research department.
SEC: Scientist charged with insider trading researched enforcement methods
The Securities and Exchange Commission charged research scientist Fei Yan on Wednesday with insider trading on confidential information about Mattress Firm Holding Corp. and Stillwater Mining Company following public announcements that they would be acquired by other companies. Yan allegedly searched the internet for "how sec detect unusual trade" before making a trade that the SEC identified as suspicious through new market surveillance tools. He also allegedly attempted to conceal the trades by using his mother's brokerage account. She lives in China and Fan also had searched the internet for instructions on "insider trading in an international account." In a parallel action, the U.S. Attorney's Office for the Southern District of New York announced criminal charges against Yan on Wednesday.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
UPDATE: Cara Therapeutics shares surge 13.7% premarket on positive trial results
Shares of Cara Therapeutics Inc. surged 13.7% in premarket trade Wednesday, after the company reported positive results in an early-stage trial of a treatment for chronic kidney disease-associated pruritus patients, or CKD-aP. Pruritus, or itch, is a common symptom for patients with chronic renal failure, affecting about half of those with stage 3 to 5 CKD. Cara said results from the Phase 1 trial of Oral CR845 in chronic kidney disease patients undergoing hemodialysis showed all four tablet strengths were well-tolerated on a daily basis or after dialysis three times a week. CR845 is a peripherally acting kappa opioid receptor agonist currently in development for the treatment of acute and chronic pain and pruritus, said Cara. Plasma levels of CR845 attained after oral administration of the 1.0 mg tablet strength were close to those attained with the 1.0 mcg/kg I.V. CR845 dose, "which demonstrated significant clinical benefit" in another recent trial, the company said. Frédérique Menzaghi, Ph.D., vice president of research and development at Cara, said the data will inform the design of a planned Oral CR845 pruritus clinical program in the non-dialysis CKD-aP population, which the company is planning to start later this year. Cara shares have gained 35% in 2017, while the S&P 500 has gained 8%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
AMD's stock surges to lead S&P 500 gainers in active trade
Shares of Advanced Micro Devices Inc. surged 3.9% in active midday trade Friday, enough to pace the S&P 500's gainers, amid a broad rally in semiconductor stock. Volume topped 49 million shares within two hours after the open, which is already more than half the full-day average, and enough to make the stock the most actively traded on major U.S. exchanges. The PHLX Semiconductor Index hiked up 1.6%, as the stocks of three other chip companies were among the top S&P 500's gainers: Lam Research Corp.'s ran up 3.1%, Applied Materials Inc.'s climbed 3.0% and Nvidia Corp.'s rallied 2.1%. Morgan Stanley analyst Joseph Moore raised his stock price target for Applied Materials to $52 from $47, and for Lam Research to $168 from $135. Moore said he believes capital spending in chips and display is continuing to improve, and that memory strength is driving an "unprecedented" memory cash flow. AMD's stock has now rallied 19% year to date, while the SOX has rallied 16% and the S&P 500 has gained 8.2%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Weird Science: First jobs of some leading scientists
NEW YORK (Reuters) - While top scientists may be deploying their brainpower on critical projects such as climate change research and conservation, they often entered the workforce in far more modest...
BRIEF-Tomtom is developing lane level traffic technology with Cisco
TOMTOM NV: * IT IS DEVELOPING ULTRA-FAST LANE LEVEL TRAFFIC TECHNOLOGY SUPPORTING AUTONOMOUS DRIVING AND SMARTER MOBILITY. * RESEARCH WILL BE DONE IN COOPERATION WITH CISCO Source text for Eikon: Further company coverage:
China will drive 20% cross-border e-commerce growth to $627 billion by 2022: Forrester
Cross-border e-commerce will grow 20% to $627 billion by 2022 with China driving the increase, according to the latest research from Forrester. Over that five year period, cross-border e-commerce growth will outpace domestic growth, the data said. As shoppers become more sophisticated, they are searching for cheaper goods. Increases in cross-border e-commerce are also driving the development of new services, like one from Paypal Holdings Inc. to manage costly returns. Two-thirds of cross-border online shopping is done through marketplaces, with clothes and consumer electronics the most popular purchases. The SPDR S&P Retail ETF is down 8.2% for the year to date while the S&P 500 index is up 8.6% for the period.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
In Russia's Tech Center, Scientists Face Rewarding But Unpredictable Life
Research institutes in Novosibirsk were built as innovation centers in the USSR. Despite the brain drain, scientists and techies remain, but life for successful entrepreneurs can be unpredictable.
U.S. office vacancy rate flat in second quarter - Reis
June 28 (Reuters) - U.S. office vacancy rate was flat at 16
percent in the second quarter of 2017, compared with the
preceding quarter, according to real estate research firm Reis
Business confidence on the up, Lloyds survey finds
But companies are having trouble recruiting skilled workers, the research says.
Greece credit rating upgraded at Moody's, outlook revised to stable
Greece's sovereign bond rating was upgraded one notch to Caa2 from Caa3 at Moody's Investors Service, citing the release of a EUR8.5 billion tranche under the country's adjustment program allowing the repayment of debt, improved fiscal prospects and tentative signs of a stabilizing economy. The outlook was revised to positive, which implies another upgrade is likely, from stable. The sovereign bond rating is still 8 notches below investment grade. The short-term debt rating was affirmed at not prime. "Beyond the near-term impact of allowing Greece to repay upcoming maturities, we consider the conclusion of the review to be a positive signal regarding the future path of the programme, as it required the Greek government to legislate a number of important reform measures," Moody's said in a research note. "The decision to assign a positive outlook to the Caa2 rating reflects Moody's view that the prospects for a successful conclusion of Greece's third adjustment programme have improved, which in turn raises the likelihood of further debt relief." Greece's Athex Composite Share Price Index has rallied 27.5% year to date, while the S&P 500 has gained 8.9%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
GOP health bill boosts hospital, health insurer and drug stocks
Hospital system stocks rallied as much as 8% on Thursday following the release of the Senate GOP health bill, which appears to be more favorable to hospitals than the House of Representatives bill passed in early May. Tenet Healthcare Corporation shares jumped 8%, Community Health Systems Inc. shares skyrocketed 8.2%, HCA Healthcare Inc. shares rose 3.6% and Universal Health Services Inc. shares lifted 2.6% in midday trade, compared with a 1.6% rise in the Health Care Select Sector SPDR . Health insurer stocks also rose Tuesday, with UnitedHealth Group shares up 1.4%, Aetna Inc. stock rising 1.1%, Humana Inc. shares lifting 1.3% and Anthem Inc. shares up 0.9%, compared with a 0.2% rise in the S&P 500 . The Senate health bill "tries to phase in the pain" of changes to the Affordable Care Act like Medicaid spending cuts, said Spencer Perlman, director of health-care research at Veda Partners, who described the Senate plan as having "the same architecture" but "nicer furnishings." Still, the benefit for hospitals is only in the short-term and thus probably overdone, he said. "Clearly, the Senate bill is viewed as less disruptive than the House bill to the number of people currently receiving insurance," said Stephanie Miller, senior analyst at Height Securities. But "the initial reaction may have oversimplified how different this bill is," she said, predicting that stocks that have risen on the news may be "rebalancing" in the coming days. Drug stocks also rose in Tuesday trade, with the SPDR S&P Pharmaceutical ETF rising 1.7% and the SPDR S&P Biotech ETF rising 1.6%, which could be happening because the health bill has given investors confidence in Republicans achieving another legislative priority, tax reform, Miller said. Shares of the Health Care Select Sector SPDR have risen 8.7% over the last three months, compared with a 3.9% rise in the S&P 500 . Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Should you buy Twitter's stock price that's exploding Today?
Twitter is rallying on an analyst note from Cleveland Research that points to positive feedback from advertisers on the firm's live content platform. Shares are rallying more than 6% in Wednesday's trading session.
Video provided by TheStreet
Chesapeake Energy's stock sinks after Macquarie turns bearish
Shares of Chesapeake Energy Corp. sank 5.4% toward an 11-month low in midday trade Wednesday, after Macquarie Research turned bearish on the oil and gas explorer, citing concerns that the company is ill-equipped to deal with another drop in oil prices. Analyst Paul Grigel downgraded the stock to a rare underperform rating from neutral and slashed his stock price target to $3.50, which is 25% below current levels, from $6.00. Only 5.8% of the U.S. companies covered by Macquarie are rated underperform. Grigel said the lower outlook for crude prices pressures Chesapeake's fundamentals given the company's recent efforts to increase its oil exposure over natural gas. "While the company has made strides in repositioning itself, it simply isn't far enough along to sustainably compete in a lower-for-longer crude world," Grigel wrote in a research note. Continuous crude oil futures tumbled 1.6% toward a 10 1/2-month low, and have now plunged more than 21% from the February peak. And although the company has been selling assets to pay down its high debt load, Grigel said he is still estimates a "material outspend on high leverage with concerns around liquidity." The stock has plummeted 34% year to date, while the SPDR Energy Select Sector ETF has shed 15% and the S&P 500 has gained 8.8%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Sangamo's stock plunges after large stock offering priced well below recent prices
Shares of Sangamo Therapeutics Inc. tumbled 9.8% in premarket trade Wednesday, after the developer for genomic therapies priced a public offering of common stock well below the previous session's closing price. The company said it sold 10 million shares of stock at $7.25 a share to raise $72.5 million. The number of shares represents about 14% of the shares outstanding, while the price was 11.6% below Tuesday's close of $8.20, which was just below the 16-month closing high of $8.40 reached on May 15. The company said it plans to use the proceeds from the share offering for working capital and other general corporate purposes, including research and development. The stock has shot up 169% year to date through Tuesday, while the iShares Nasdaq Biotechnology ETF has climbed 14% and the S&P 500 has gained 8.9%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Tesla replaces head of Autopilot software after six months
Tesla Inc. has parted ways with Autopilot software chief Chris Lattner after just six months. Tesla had lured Lattner from Apple Inc. in January. In a tweet Tuesday night, Lattner said: "Turns out that Tesla isn't a good fit for me after all. I'm interested to hear about interesting roles for a seasoned engineering leader!" In a statement, Tesla confirmed Lattner was leaving: "Chris just wasn't the right fit for Tesla, and we've decided to make a change. We wish him the best." Lattner's position will be filled by new hire Andrej Karpathy, who will be director of artificial intelligence and Autopilot Vision, as well as Tesla hardware division chief Jim Keller, who will add software to his responsibilities, according to a Tesla spokesperson. Karpathy has expertise in deep learning, and is a veteran of Alphabet Inc.'s Google and most recently worked as a research scientist at OpenAI.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
BRIEF-Galapagos announces successful completion of Phase 1
* GALAPAGOS' RESEARCH AND DEVELOPMENT UPDATE 2017: RAPIDLY
ADVANCING OUR PRODUCT CANDIDATES
AMD picked for research on 'supercomputer' hardware architecture
AMD said late Thursday it has been selected by a Department of Energy "supercomputing" project to help research next-generation supercomputing hardware architecture. The three-year program provides R&D funding "to drive critical advances of next-generation supercomputing hardware technologies," the company said in a statement. Shares of AMD rose 1.5% in late trading after ending the regular trading session down 2.3%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
BRIEF-Helix Biopharma Q3 loss per share $0.03
* Co will require additional financing in near term, in
future to see current research and development initiates through
Emkay and DBS ink pact for equity research distribution
This move would help Emkay expand its presence globally
Independent Bank Corp.INDB
Independent Bank CorporationIBCP
Independent Bank Group, IncIBTX
Industrial Services of America, Inc.IDSA
Infinity Pharmaceuticals, Inc.INFI
Infinity Property and Casualty CorporationIPCC
Information Services Group, Inc.III